Building Trust: Clinical Trial Diversity
The groundbreaking medical research happening today is laying the foundation for a new golden era of medicine. Clinical trials are a vital step in not just ensuring that new innovations are effective, but that they work for all patients.
On June 22, during The Atlantic’s Health Equity Summit, PhRMA hosted a conversation on clinical trial diversity. PhRMA COO Lori Reilly and Genentech Vice President and Chief Diversity Officer Quita Highsmith focused on the work Genentech has done to build diversity in clinical trials and the important lessons learned along the way.
June 22, 2021 at 11:00am ET
- Lori M. Reilly, Chief Operating Officer, PhRMA
- Quita Highsmith, Vice President and Chief Diversity Officer, Genentech